Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Gains from Investment Securities: 2012-2025

Historic Gains from Investment Securities for Nutex Health (NUTX) over the last 11 years, with Q3 2025 value amounting to $1.4 million.

  • Nutex Health's Gains from Investment Securities rose 19152.89% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 8571.92%. This contributed to the annual value of $4.6 million for FY2024, which is 3281.22% up from last year.
  • Per Nutex Health's latest filing, its Gains from Investment Securities stood at $1.4 million for Q3 2025, which was up 19152.89% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Nutex Health's Gains from Investment Securities peaked at $6.5 million during Q1 2022, and registered a low of $472000.0 during Q2 2024.
  • Moreover, its 4-year median value for Gains from Investment Securities was $2.1 million (2024), whereas its average is $2.8 million.
  • Per our database at Business Quant, Nutex Health's Gains from Investment Securities crashed by 6592.52% in 2021 and then soared by 68001.1% in 2022.
  • Nutex Health's Gains from Investment Securities (Quarter) stood at $3.0 million in 2021, then surged by 73.59% to $5.1 million in 2022, then plummeted by 47.47% to $2.7 million in 2024, then plummeted by 47.82% to $1.4 million in 2025.
  • Its Gains from Investment Securities was $1.4 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.4 million in Q1 2025.